Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

Condition:   Nasopharyngeal Carcinoma
Intervention:   Drug: Docetaxel, Cisplatin, 5-FU and Cetuximab
Sponsors:   Hong Kong Nasopharyngeal Cancer Study Group Limited;   The University of Hong Kong;   Sanofi;   Merck Sharp & Dohme Corp.;   Roche Pharma AG
Recruiting - verified August 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/2bcoao9
via IFTTT